News

Since 2012, GSK owned a minority stake in Glycovaxyn, which has developed a biological conjugation platform technology that could help in the development of new prophylactic and therapeutic

The company said that TZ101 could potentially transform hematopoietic stem cell transplantation by reducing patient morbidity and mortality from GVHD. GVHD is a serious, life-threating complication of stem

Under the deal, Accelovance will support Panacea’s clinical development strategies by providing scientific/medical and regulatory expertise. Additionally, Accelovance will also provide contract research organization (CRO) support through project

The exclusive license was received through an amendment to Lion’s previously granted, non-exclusive, worldwide license to certain NIH issued and pending patent applications for the use of TIL

The U.S. Centers for Disease Control and Prevention (CDC) has identified C. difficile as an "urgent public health threat" that often occurs in people who have had recent

The meeting brought together all members of the Consortium to plan the necessary preclinical studies that will be required to advance its Cell-in-a-Box(R) live-cell encapsulated product for the

Inoviem Scientific leverages two proprietary technologies to offer the pharmaceutical industry access at all stages of drug development. Inoviem supports all stages of drug development, from drug discovery

Equipped to ensure cost-effective, high-quality production of API using microbial expression systems, Enteris BioPharma offers pharmaceutical companies a full array of services to meet their manufacturing needs, from

RAK Pharmaceuticals, based in Bangladesh, was a subsidiary of RAK Ceramics and produces a variety of industry compliant tablets, capsules and syrups that are fit quality wise to